Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A conservative viewpoint on linkage in Alzheimer's disease Roses, Allen D.
1989
10 5 p. 427-429
3 p.
artikel
2 Additional arrows for the β-amyloid target Cordell, Barbara
1989
10 5 p. 468-470
3 p.
artikel
3 A different view of A68 and amyloid Davies, Peter
1989
10 5 p. 408-409
2 p.
artikel
4 A functional framework for neurotrophic activities Haverkamp, Lanny J.
1989
10 5 p. 537-539
3 p.
artikel
5 Age page 1989
10 5 p. 652-654
3 p.
artikel
6 Alzheimer's amyloid: Is it possible it's not rotten to the core? Bartus, Raymond T.
1989
10 5 p. 479-
1 p.
artikel
7 Alzheimer's disease is a degenerative disorder Katzman, Robert
1989
10 5 p. 581-582
2 p.
artikel
8 Amyloid and Alzheimer's disease: A question of specificity Perry, Elaine K.
1989
10 5 p. 473-474
2 p.
artikel
9 Amyloid and Alzheimer's disease—Cause or effect? Yankner, Bruce A.
1989
10 5 p. 470-471
2 p.
artikel
10 Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer's disease Goedert, M.
1989
10 5 p. 405-406
2 p.
artikel
11 A new orientation to an old problem: It's simply a matter of time Bartus, Raymond T.
1989
10 5 p. 449-
1 p.
artikel
12 Antiamyloid therapy—a distant horizon Shelanski, Michael L.
1989
10 5 p. 476-477
2 p.
artikel
13 Author index 1989
10 5 p. 659-
1 p.
artikel
14 Author's response to commentaries Selkoe, Dennis J.
1989
10 5 p. 412-414
3 p.
artikel
15 Authors' response to commentaries Hefti, F.
1989
10 5 p. 552-553
2 p.
artikel
16 Authors' response to commentaries Snow, Alan D.
1989
10 5 p. 510-512
3 p.
artikel
17 Authors' response to commentaries Caputo, Claudia B.
1989
10 5 p. 477-478
2 p.
artikel
18 Authors' response to commentaries St George-Hyslop, P.H.
1989
10 5 p. 446-448
3 p.
artikel
19 Authors' response to commentaries Greenamyre, J.Timothy
1989
10 5 p. 618-620
3 p.
artikel
20 Authors' response to commentaries Butcher, Larry L.
1989
10 5 p. 588-590
3 p.
artikel
21 Author's response to commentaries Harbaugh, Robert E.
1989
10 5 p. 648-650
3 p.
artikel
22 Beta-amyloid deposition and paired helical filament formation: Which histopathological feature is more significant in Alzheimer's disease? Dickson, Dennis W.
1989
10 5 p. 402-404
3 p.
artikel
23 Calendar 1989
10 5 p. 655-657
3 p.
artikel
24 Causes of cell damage in hypoxia/ischemia, aging and Alzheimer's disease Gibson, Gary
1989
10 5 p. 608-609
2 p.
artikel
25 Cerebral amyloidosis, ageing and Alzheimer's disease; A contribution from studies on Down's syndrome Mann, David M.A.
1989
10 5 p. 397-399
3 p.
artikel
26 Combining CNS transplantation and gene transfer Breakefield, Xandra O.
1989
10 5 p. 647-648
2 p.
artikel
27 Considerations in the treatment of neurological disorders with trophic factors Morgan, David G.
1989
10 5 p. 547-549
3 p.
artikel
28 Cytoskeletal protein pathology and the formation of beta-amyloid fibers in Alzheimer's disease Wisniewski, Henry M.
1989
10 5 p. 409-412
4 p.
artikel
29 Cytoskeleton and NGF in the pathogenesis and treatment of Alzheimer's disease Shelanski, Michael L.
1989
10 5 p. 577-
1 p.
artikel
30 Delivery of neuroactive compounds to the brain: Potential utility of genetically modified cells Tuszynski, Mark H.
1989
10 5 p. 644-645
2 p.
artikel
31 Designer genes: Current fad or lasting fashion? Bartus, Raymond T.
1989
10 5 p. 415-
1 p.
artikel
32 Detrimental actions of neurotrophic agents Hefti, Franz
1989
10 5 p. 583-
1 p.
artikel
33 Direct comparisons of CNS directed therapies are needed Gash, Don M.
1989
10 5 p. 645-646
2 p.
artikel
34 Drug delivery to the brain: The problem lurking behind the problem? Bartus, Raymond T.
1989
10 5 p. 621-
1 p.
artikel
35 Epidermal growth factor receptor ≠ nerve growth factor Williams, Lawrence R.
1989
10 5 p. 586-587
2 p.
artikel
36 Evidence for etiologic heterogeneity in Alzheimer's disease Bird, Thomas D.
1989
10 5 p. 432-434
3 p.
artikel
37 Excitatory amino acids and Alzheimer's disease Greenamyre, J.Timothy
1989
10 5 p. 593-602
10 p.
artikel
38 Excitatory amino acids and Alzheimer's disease: Idle thoughts on an exciting subject McGeer, Edith G.
1989
10 5 p. 614-616
3 p.
artikel
39 Familial Alzheimer's disease: Genetic analysis related to disease heterogeneity, Down syndrome and human brain evolution Schapiro, Mark B.
1989
10 5 p. 435-436
2 p.
artikel
40 Familial Alzheimer's disease: Progress and problems St George-Hyslop, Peter H.
1989
10 5 p. 417-425
9 p.
artikel
41 Focusing on IL1-promotion of β-amyloid precursor protein synthesis as an early event in Alzheimer's disease Blume, Arthur J.
1989
10 5 p. 406-408
3 p.
artikel
42 Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases Hefti, F.
1989
10 5 p. 515-533
19 p.
artikel
43 Genetics and Alzheimer's disease: Notes of an environment watcher (with apologies to L. Thomas) Perl, Daniel P.
1989
10 5 p. 444-446
3 p.
artikel
44 Genetics and the diagnosis of Alzheimer's disease: True signals and original din Heston, Leonard L.
1989
10 5 p. 443-444
2 p.
artikel
45 Genetic studies of typical Alzheimer's disease Mohs, Richard C.
1989
10 5 p. 438-439
2 p.
artikel
46 Genetic studies support a neuronal origin for the beta amyloid polypeptide Neve, Rachael L.
1989
10 5 p. 400-402
3 p.
artikel
47 Heterogeneity in Alzheimer's disease Folstein, Marshal F.
1989
10 5 p. 434-435
2 p.
artikel
48 How well do we understand neurotrophic factors and the control of CNS neuronal growth? Walicke, Patricia Ann
1989
10 5 p. 535-537
3 p.
artikel
49 Increasing amyloid peptide precursor production and its impact on Alzheimer's disease Vitek, Michael P.
1989
10 5 p. 471-473
3 p.
artikel
50 Information related to research funding, grants and awards 1989
10 5 p. 651-
1 p.
artikel
51 Methodological considerations in cognitive disorders or: “The baby needs enough bath water” Read, Stephen
1989
10 5 p. 634-635
2 p.
artikel
52 Modelling the occurrence and pathology of Alzheimer's disease Hardy, J.A.
1989
10 5 p. 429-431
3 p.
artikel
53 Molecular genetic analysis of early onset familial Alzheimer's disease Van Broeckhoven, Christine L.
1989
10 5 p. 437-438
2 p.
artikel
54 Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease Selkoe, Dennis J.
1989
10 5 p. 387-395
9 p.
artikel
55 Nerve growth factor in Alzheimer's disease: To treat or not to treat? Mobley, William C.
1989
10 5 p. 578-580
3 p.
artikel
56 Neurite outgrowth and the amyloid protein precursor Hammond, David N.
1989
10 5 p. 575-576
2 p.
artikel
57 Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's disease Butcher, Larry L.
1989
10 5 p. 557-570
14 p.
artikel
58 Neurotrophic factors and Alzheimer's disease Wainer, Bruce H.
1989
10 5 p. 540-542
3 p.
artikel
59 Neurotrophic factors: Can the degenerating brain be induced to heal itself? Bartus, Raymond T.
1989
10 5 p. 513-
1 p.
artikel
60 Neurotrophic factors: The good, the bad or the ugly? Bartus, Raymond T.
1989
10 5 p. 555-
1 p.
artikel
61 New directions in CNS drug delivery Langer, Robert
1989
10 5 p. 642-644
3 p.
artikel
62 NGF and Alzheimer's disease—Considerations and caveats Yankner, Bruce A.
1989
10 5 p. 546-547
2 p.
artikel
63 NGF and Alzheimer's disease: Unfulfilled promise and untapped potential Kordower, Jeffrey H.
1989
10 5 p. 543-544
2 p.
artikel
64 N-methyl-D-aspartate receptors and Alzheimer's disease Cotman, C.W.
1989
10 5 p. 603-605
3 p.
artikel
65 Noninvasive drug delivery to the brain Brewster, Marcus E.
1989
10 5 p. 638-639
2 p.
artikel
66 Non-NMDA receptor-mediated neuronal injury in Alzheimer's disease? Choi, Dennis W.
1989
10 5 p. 605-606
2 p.
artikel
67 Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders Harbaugh, Robert E.
1989
10 5 p. 623-629
7 p.
artikel
68 Novel drug delivery systems: Opportunities and caveats Drachman, David A.
1989
10 5 p. 632-633
2 p.
artikel
69 Novel therapy for Alzheimer's disease DeFeudis, F.V.
1989
10 5 p. 467-468
2 p.
artikel
70 Plasticity, pathology, and Alzheimer's disease Geddes, J.W.
1989
10 5 p. 571-573
3 p.
artikel
71 Potential roles of protease inhibitors in Alzheimer's disease Abraham, Carmela R.
1989
10 5 p. 463-465
3 p.
artikel
72 Preface Bartus, Raymond T.
1989
10 5 p. 381-
1 p.
artikel
73 Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease Margolis, Richard U.
1989
10 5 p. 500-502
3 p.
artikel
74 Proteoglycans in amyloidogenesis Shirahama, Tsuranobu
1989
10 5 p. 508-510
3 p.
artikel
75 Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses Snow, Alan D.
1989
10 5 p. 481-497
17 p.
artikel
76 Proteoglycans in the pathogenesis of amyloidosis Linker, Alfred
1989
10 5 p. 507-508
2 p.
artikel
77 Pyramidal neuron loss and “glycine-site therapy”: A need for an animal model and study in late-life depression Bowen, David M.
1989
10 5 p. 616-618
3 p.
artikel
78 Role of neurotrophic factors in Alzheimer's disease Chen, Karen S.
1989
10 5 p. 545-546
2 p.
artikel
79 Selective neuronal vulnerability and the distribution of N-methyl-D-aspartate (NMDA) receptors Lee, Kevin S.
1989
10 5 p. 609-611
3 p.
artikel
80 Selectivity of excitotoxic mechanisms in Alzheimer's disease May, Patrick C.
1989
10 5 p. 606-608
3 p.
artikel
81 Site-specific drug delivery to CNS: Old and new Hollister, Leo E.
1989
10 5 p. 631-
1 p.
artikel
82 Strategies for drug delivery through the blood-brain barrier Pardridge, William M.
1989
10 5 p. 636-637
2 p.
artikel
83 Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers Peterson, Gary M.
1989
10 5 p. 639-640
2 p.
artikel
84 The amyloid proteins of Alzheimer's disease as potential targets for drug therapy Caputo, Claudia B.
1989
10 5 p. 451-461
11 p.
artikel
85 The biological roles of heparan sulfate proteoglycans in the nervous system Schubert, David
1989
10 5 p. 504-506
3 p.
artikel
86 The etiology of Alzheimer's disease: An epidemiologic point of view Rocca, Walter A.
1989
10 5 p. 440-441
2 p.
artikel
87 The genetics of Alzheimer's disease—Where does it lead? Whatley, Stephen A.
1989
10 5 p. 441-443
3 p.
artikel
88 The impending Alzheimer's crisis: Can we be saved by the revolution? Bartus, Raymond T.
1989
10 5 p. 383-384
2 p.
artikel
89 Theme and variations on a string of amyloid Kisilevsky, Robert
1989
10 5 p. 499-500
2 p.
artikel
90 The necessity of human trials of putative therapies for Alzheimer's disease Knopman, David
1989
10 5 p. 633-634
2 p.
artikel
91 The role of neuronal energy in the neurotoxicity of excitatory amino acids Henneberry, Richard C.
1989
10 5 p. 611-613
3 p.
artikel
92 The study of Alzheimer's pathology: The long and winding road Bartus, Raymond T.
1989
10 5 p. 385-386
2 p.
artikel
93 The ultimate Shakespearean tragedy: Are selective areas of the brain committing suicide? Bartus, Raymond T.
1989
10 5 p. 591-
1 p.
artikel
94 The use of hollow polymer fibers for the delivery of bioactive molecules to the brain Springer, Joe E.
1989
10 5 p. 640-641
2 p.
artikel
95 Toward a therapeutic strategy based on amyloid precursor protein: Unanswered questions Davis, Kenneth L.
1989
10 5 p. 475-476
2 p.
artikel
96 Towards trophic factor pharmacology? Cuello, A.Claudio
1989
10 5 p. 539-540
2 p.
artikel
97 Trophic factors and Alzheimer's disease Phelps, Creighton H.
1989
10 5 p. 584-586
3 p.
artikel
98 Venn diagrams and neuronal vulnerability Sapolsky, Robert M.
1989
10 5 p. 613-614
2 p.
artikel
99 What is the significance of the binding of proteoglycans to amyloid? Caputo, Claudia B.
1989
10 5 p. 503-504
2 p.
artikel
100 What mediates between β-amyloid and paired helical filaments? Ihara, Yasuo
1989
10 5 p. 573-574
2 p.
artikel
101 What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease Benditt, Earl P.
1989
10 5 p. 506-
1 p.
artikel
102 Why do neurons die when deprived of trophic factor? Johnson Jr., Eugene M.
1989
10 5 p. 549-552
4 p.
artikel
103 Will neurotrophic agents be harmful in Alzheimer's disease? Appel, Stanley H.
1989
10 5 p. 580-581
2 p.
artikel
104 Zeroing in on amyloid proteins in Alzheimer disease therapy Festoff, Barry W.
1989
10 5 p. 465-466
2 p.
artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland